# Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage

> **NCT02274428** · PHASE1 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Mesenchymal Stromal Cells

## Interventions

- **DRUG:** pneumostem

## Key facts

- **NCT ID:** NCT02274428
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02274428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02274428, "Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02274428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*